Published in Eur J Nutr on January 12, 2014
Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health (2014) 1.05
Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. Int J Mol Sci (2014) 0.87
Mechanisms and therapeutic effectiveness of lactobacilli. J Clin Pathol (2015) 0.85
Characterization and pharmacological potential of Lactobacillus sakei 1I1 isolated from fresh water fish Zacco koreanus. Daru (2016) 0.78
Faecal Metaproteomic Analysis Reveals a Personalized and Stable Functional Microbiome and Limited Effects of a Probiotic Intervention in Adults. PLoS One (2016) 0.76
An in vivo invertebrate evaluation system for identifying substances that suppress sucrose-induced postprandial hyperglycemia. Sci Rep (2016) 0.75
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial. Diabetes Ther (2017) 0.75
Antibacterial effects of Lactobacillus isolates of curd and human milk origin against food-borne and human pathogens. 3 Biotech (2017) 0.75
In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complement Altern Med (2016) 0.75
Probiotic Characteristics of Lactobacillus curvatus DN317, a Strain Isolated from Chicken Ceca. Probiotics Antimicrob Proteins (2017) 0.75
Some current applications, limitations and future perspectives of lactic acid bacteria as probiotics. Food Nutr Res (2017) 0.75
Antibiotic sensitivity pattern of indigenous lactobacilli isolated from curd and human milk samples. 3 Biotech (2017) 0.75
Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 18.83
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet (2002) 9.48
Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol (1990) 7.65
Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis. J Eukaryot Microbiol (1999) 4.09
The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol (2011) 3.13
A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One (2012) 1.86
α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharm Sci (2012) 1.47
Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Rev Med Chem (2010) 1.43
alpha-Glucosidase inhibitors. Endocrinol Metab Clin North Am (1997) 1.31
Identification of lactobacilli by pheS and rpoA gene sequence analyses. Int J Syst Evol Microbiol (2007) 1.30
Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions. Antiviral Res (2013) 1.29
A PCR-based method for identification of lactobacilli at the genus level. FEMS Microbiol Lett (2002) 1.22
The complete genome sequence of the acarbose producer Actinoplanes sp. SE50/110. BMC Genomics (2012) 1.21
Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review. Clin Ther (2012) 1.12
α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci (2012) 1.09
Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases. BioDrugs (2007) 0.95
Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism. BMC Complement Altern Med (2012) 0.94
Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives. Diabetes Metab Res Rev (2013) 0.94
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation. Diab Vasc Dis Res (2012) 0.93
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations. Diabetes Metab Syndr Obes (2012) 0.91
The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes. Cardiovasc Diabetol (2013) 0.87
Chemistry, physiological properties, and microbial production of hydroxycitric acid. Appl Microbiol Biotechnol (2007) 0.85
Inhibitory effect of Azadirachta indica A. juss leaf extract on the activities of alpha-amylase and alpha-glucosidase. Pak J Biol Sci (2013) 0.80
Production of the α-glycosidase inhibitor 1-deoxynojirimycin from Bacillus species. Food Chem (2012) 0.80
Effects of the alpha-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications. Diabetes Metab Res Rev (1999) 0.79
Proteolytic profiles and angiotensin-I converting enzyme and alpha-glucosidase inhibitory activities of selected lactic acid bacteria. J Food Sci (2008) 0.78
Expression and purification of two Family GH31 α-glucosidases from Bacteroides thetaiotaomicron. Protein Expr Purif (2012) 0.77
Enzymatic properties of a thermostable α-glucosidase from acidothermophilic crenarchaeon Sulfolobus tokodaii strain 7. J Microbiol Biotechnol (2013) 0.77
Influence of alternansucrase-derived oligosaccharides and other carbohydrates on alpha-galactosidase and alpha-glucosidase activity in Bifidobacterium adolescentis. Lett Appl Microbiol (2007) 0.76
Effects of Lactobacillus acidophilus on gut microflora metabolic biomarkers in fed and fasted rats. Clin Nutr (2009) 0.76
Screening for glycosidase activities of lactic acid bacteria as a biotechnological tool in oenology. World J Microbiol Biotechnol (2011) 0.75
Inhibitory effect of components from Streptomyces species on alpha-glucosidase and alpha-amilase of different origin. Prikl Biokhim Mikrobiol (2013) 0.75
Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite. Nature (2007) 7.42
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br J Pharmacol (2009) 1.41
Rapid and sensitive detection of Mycobacterium avium subsp. paratuberculosis in bovine milk and feces by a combination of immunomagnetic bead separation-conventional PCR and real-time PCR. J Clin Microbiol (2004) 1.34
Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS One (2009) 1.31
Maximizing capture efficiency and specificity of magnetic separation for Mycobacterium avium subsp. paratuberculosis cells. Appl Environ Microbiol (2010) 1.13
Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease. Anal Chem (2013) 1.08
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes. Front Biosci (2008) 1.06
Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells. Indian J Med Res (2011) 1.05
Surveillance of bulk raw and commercially pasteurized cows' milk from approved Irish liquid-milk pasteurization plants to determine the incidence of Mycobacterium paratuberculosis. Appl Environ Microbiol (2004) 0.99
Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep (2011) 0.99
Culture phenotypes of genomically and geographically diverse Mycobacterium avium subsp. paratuberculosis isolates from different hosts. J Clin Microbiol (2011) 0.99
Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br J Nutr (2010) 0.95
Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives. Diabetes Metab Res Rev (2013) 0.94
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline. Eur J Pharmacol (2009) 0.92
Interaction between Mycobacterium avium subsp. paratuberculosis and environmental protozoa. BMC Microbiol (2006) 0.91
Optimization of a phage amplification assay to permit accurate enumeration of viable Mycobacterium avium subsp. paratuberculosis cells. Appl Environ Microbiol (2009) 0.90
Acute and chronic effects of dietary fatty acids on cholecystokinin expression, storage and secretion in enteroendocrine STC-1 cells. Mol Nutr Food Res (2010) 0.89
Production and evaluation of antibodies and phage display-derived peptide ligands for immunomagnetic separation of Mycobacterium bovis. J Clin Microbiol (2012) 0.88
Expression of the atpD gene in probiotic Lactobacillus plantarum strains under in vitro acidic conditions using RT-qPCR. Res Microbiol (2010) 0.88
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1. Eur J Pharmacol (2007) 0.88
Improved detection of Mycobacterium bovis infection in bovine lymph node tissue using immunomagnetic separation (IMS)-based methods. PLoS One (2013) 0.88
Management of metabolic syndrome through probiotic and prebiotic interventions. Indian J Endocrinol Metab (2012) 0.87
Inward rectifier potassium channels in the HL-1 cardiomyocyte-derived cell line. J Cell Physiol (2010) 0.87
Relative gene expression of bile salt hydrolase and surface proteins in two putative indigenous Lactobacillus plantarum strains under in vitro gut conditions. Mol Biol Rep (2011) 0.86
Multiplex detection of plant pathogens using a microsphere immunoassay technology. PLoS One (2013) 0.86
UV light inactivation of Mycobacterium avium subsp. paratuberculosis in milk as assessed by FASTPlaqueTB phage assay and culture. Appl Environ Microbiol (2007) 0.85
The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling. Br J Pharmacol (2012) 0.85
Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix. Basic Res Cardiol (2015) 0.85
Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R(-/-) mice. Biol Chem (2011) 0.85
Role of surface layer collagen binding protein from indigenous Lactobacillus plantarum 91 in adhesion and its anti-adhesion potential against gut pathogen. Microbiol Res (2013) 0.84
Antioxidative potential of lactobacilli isolated from the gut of Indian people. Mol Biol Rep (2012) 0.84
Application of a peptide-mediated magnetic separation-phage assay for detection of viable Mycobacterium avium subsp. paratuberculosis to bovine bulk tank milk and feces samples. J Clin Microbiol (2011) 0.84
Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation. Eur J Endocrinol (2009) 0.84
Occurrence of Mycobacterium avium subsp. paratuberculosis in untreated water in Northern Ireland. Appl Environ Microbiol (2005) 0.84
Effect of environmental factors on production of lichenin, a chromosomally encoded bacteriocin-like compound produced by Bacillus licheniformis 26L-10/3RA. Microbiol Res (2005) 0.83
Rapid assessment of the viability of Mycobacterium avium subsp. paratuberculosis cells after heat treatment, using an optimized phage amplification assay. Appl Environ Microbiol (2010) 0.83
Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli. Genes Nutr (2013) 0.82
Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37). Biol Chem (2005) 0.81
A molecular beacon-based duplex real-time polymerase chain reaction assay for simultaneous detection of Escherichia coli O157:H7 and Listeria monocytogenes in milk and milk products. Foodborne Pathog Dis (2009) 0.81
Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis. Appl Environ Microbiol (2008) 0.81
GIP(Lys16PAL) and GIP(Lys37PAL): novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potential. J Med Chem (2006) 0.81
Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone. Expert Opin Investig Drugs (2010) 0.81
Simultaneous detection of Listeria monocytogenes and Salmonella spp. in dairy products using real time PCR-melt curve analysis. J Food Sci Technol (2011) 0.81
Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice. Biol Chem (2004) 0.81
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice. Peptides (2005) 0.80
Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes. Br J Pharmacol (2014) 0.80
Application of multiplex PCR assay based on uidR and fliCH7 genes for detection of Escherichia coli O157:H7 in milk. J Gen Appl Microbiol (2013) 0.80
Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes. Biol Chem (2007) 0.79
Effects of long-term exposure to nicotinamide and sodium butyrate on growth, viability, and the function of clonal insulin secreting cells. Endocr Res (2004) 0.79
Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging mice. Exp Gerontol (2005) 0.79
Metabolic and structural properties of human obestatin {1-23} and two fragment peptides. Peptides (2010) 0.79
Phage display-derived binders able to distinguish Listeria monocytogenes from other Listeria species. PLoS One (2013) 0.79
Examining acute and chronic effects of short- and long-chain fatty acids on peptide YY (PYY) gene expression, cellular storage and secretion in STC-1 cells. Eur J Nutr (2012) 0.78
Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16). Regul Pept (2006) 0.78
A scorpion probe-based real-time PCR assay for detection of E. coli O157:H7 in dairy products. Foodborne Pathog Dis (2009) 0.78
Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob mice. Am J Physiol Endocrinol Metab (2007) 0.78
Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity. Biochem Pharmacol (2003) 0.77
Influence of human lactoferrin expression on iron homeostasis, flavonoids, and antioxidants in transgenic tobacco. Mol Biotechnol (2013) 0.77
A novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetes. J Pharmacol Exp Ther (2005) 0.77
Grape-seed procyanidins modulate cellular membrane potential and nutrient-induced GLP-1 secretion in STC-1 cells. Am J Physiol Cell Physiol (2013) 0.77
Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells. Genes Nutr (2014) 0.77
Long-term beneficial effects of vanadate, tungstate, and molybdate on insulin secretion and function of cultured beta cells. Pancreas (2004) 0.77
Degradation, insulin secretion, and antihyperglycemic actions of two palmitate-derivitized N-terminal pyroglutamyl analogues of glucose-dependent insulinotropic polypeptide. J Med Chem (2005) 0.76
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide. Diabetes Metab Res Rev (2007) 0.76
Relative expression of bacterial and host specific genes associated with probiotic survival and viability in the mice gut fed with Lactobacillus plantarum Lp91. Microbiol Res (2013) 0.76
Hormone profiling in a novel enteroendocrine cell line pGIP/neo: STC-1. Metabolism (2012) 0.76
Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide. Biochem Pharmacol (2006) 0.76
N-acetyl-GLP-1: a DPP IV-resistant analogue of glucagon-like peptide-1 (GLP-1) with improved effects on pancreatic beta-cell-associated gene expression. Cell Biol Int (2004) 0.76
Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) mice. Biol Chem (2007) 0.76
In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1). Sci Pharm (2011) 0.75
Adhesion of indigenous Lactobacillus plantarum to gut extracellular matrix and its physicochemical characterization. Arch Microbiol (2014) 0.75
Isolation, purification and characterization of chymosin from riverine buffalo (Bubalos bubalis). J Dairy Res (2003) 0.75
Evidence of Methylobacterium spp. and Hyphomicrobium sp. in azaspiracid toxin contaminated mussel tissues and assessment of the effect of azaspiracid on their growth. Toxicon (2011) 0.75
Purification and characterization of milk clotting enzyme from goat (Capra hircus). Comp Biochem Physiol B Biochem Mol Biol (2006) 0.75
Deleterious effects of supplementation with dehydroepiandrosterone sulphate or dexamethasone on rat insulin-secreting cells under in vitro culture condition. Biosci Rep (2006) 0.75
Characterisation and biological activity of Glu3 amino acid substituted GIP receptor antagonists. Arch Biochem Biophys (2007) 0.75